Ausbil Investment Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,753
Closed -$1.34M 73
2025
Q2
$1.34M Buy
2,753
+2,135
+345% +$1.22M 0.79% 36
2025
Q1
$380K Sell
618
-1,362
-69% -$774K 0.23% 45
2024
Q4
$1.06M Buy
1,980
+1,016
+105% +$573K 0.64% 37
2024
Q3
$579K Buy
+964
New +$546K 0.2% 57
2024
Q2
Sell
-907
Closed -$581K 62
2024
Q1
$581K Sell
907
-47
-5% -$28.6K 0.29% 53
2023
Q4
$558K Buy
954
+13
+1% +$7.28K 0.3% 45
2023
Q3
$486K Sell
941
-410
-30% -$213K 0.3% 48
2023
Q2
$732K Buy
+1,351
New +$739K 0.45% 40

Other funds holding CHE

Ausbil Investment Management's CHE Position: Q3 2025 in Review

Ausbil Investment Management sold out of Chemed (CHE) in Q3 2025, closing a stake of 2,753 shares — an estimated $1.34M sold.

Ausbil Investment Management first reported a position in CHE in Q2 2023 and held it in 8 quarters. The position peaked at $1.34M in Q2 2025. 523 funds tracked by Wall St. Rank hold CHE as of Q3 2025.

  • Ausbil Investment Management reported no remaining Chemed position as of Q3 2025 after selling out during the quarter.
  • Ausbil Investment Management sold 2,753 Chemed shares in Q3 2025, an estimated $1.34M.
  • Ausbil Investment Management first reported a position in Chemed in Q2 2023 and held it in 8 quarters.
  • Ausbil Investment Management's Chemed position peaked at $1.34M in Q2 2025.
  • 523 funds tracked by Wall St. Rank held Chemed as of Q3 2025.

Based on Ausbil Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.